immunocompromised

At the recent IDWeek conference, company collaborators presented early validation data on a blood-based assay for cell-free microbial DNA.

Researchers used exome sequencing to pinpoint DOCK2 mutations as causative of early childhood immune deficiency that leads to severe infections. 

BD Diagnostics and Italian biotech firm Biodiversity said today that they will collaborate to develop a comprehensive molecular diagnostic menu for testing immunocompromised patients on the BD Max system, adding to the pipeline of assay content for the recently launched platform.

In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.